The goals of this overview on congenital insensitivity to pain (CIP) are the following.
Goal 1: Describe the clinical characteristics of congenital insensitivity to pain.
Goal 2: Review the causes of congenital insensitivity to pain.
Goal 3: Provide an evaluation strategy to identify the genetic cause of congenital insensitivity to pain in a proband.
Goal 4: Provide a brief summary of management of congenital insensitivity to pain.
Goal 5: Inform genetic risk assessment of family members of a proband with congenital insensitivity to pain.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.